Doctors begin major stem cell trial for MS patients

A major clinical trial will investigate whether stem cells can be safely used to treat multiple sclerosis (MS). It is hoped to slow, stop or even reverse the damage MS causes to the brain and spinal cord. The trial, involving up to 150 patients across Europe, is due to start later this year. Dr Paolo Muraro from Imperial College London said:
"There is very strong pre-clinical evidence that stem cells might be an effective treatment."
Researchers will collect stem cells from the bone marrow of patients, grow them in the laboratory and then re-inject them into their blood. The stem cells will make their way to the brain where it is hoped that they will repair the damage caused by MS. The MS Society hopes these new trials will eventually lead to a proven treatment.
Flame Pharma are looking for experienced Home Based CRA’s with proven Neurology experience based in Hungary to join a leading International CRO on a permanent full time basis. If you have the right experience and would like to join an expert team, dedicated to research please get in touch.